Suppression of allorecognition by use of synthetic peptides.
Colovai
A I
AI
Department of Pathology, College of Physicians and Surgeons of Columbia University, New York, New York 10032, USA.
Renna-Molajoni
E
E
Cocciolo
P L
PL
Tugulea
S
S
Liu
Z
Z
Harris
P E
PE
Suciu-Foca
N
N
Cortesini
R
R
D000595:Amino Acid Sequence; D000938:Antigen-Presenting Cells / Q000187:drug effects / Q000276:immunology* / Q000528:radiation effects; D002478:Cells, Cultured; D002999:Clone Cells; D006684:HLA-DR Antigens / Q000737:chemistry / Q000276:immunology*; D059810:HLA-DR Serological Subtypes; D006801:Humans; D008213:Lymphocyte Activation; D010446:Peptide Fragments / Q000737:chemistry / Q000494:pharmacology*; D011994:Recombinant Proteins / Q000737:chemistry / Q000276:immunology; D013329:Structure-Activity Relationship; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology*
D006684:HLA-DR Antigens; D059810:HLA-DR Serological Subtypes; C080766:HLA-DR11 antigen; D010446:Peptide Fragments; D011994:Recombinant Proteins